The latest price target for Thermo Fisher Scientific (NYSE:TMO) was reported by Morgan Stanley on January 13, 2025. The analyst firm set a price target for $647.00 expecting TMO to rise to within 12 months (a possible 15.97% upside). 40 analyst firms have reported ratings in the last year.

The latest analyst rating for Thermo Fisher Scientific (NYSE:TMO) was provided by Morgan Stanley, and Thermo Fisher Scientific maintained their overweight rating.

The last upgrade for Thermo Fisher Scientific Inc happened on July 13, 2023 when Credit Suisse raised their price target to $620. Credit Suisse previously had a neutral for Thermo Fisher Scientific Inc.

The last downgrade for Thermo Fisher Scientific Inc happened on January 24, 2024 when Barclays changed their price target from $475 to $555 for Thermo Fisher Scientific Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Thermo Fisher Scientific, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Thermo Fisher Scientific was filed on January 13, 2025 so you should expect the next rating to be made available sometime around January 13, 2026.

While ratings are subjective and will change, the latest Thermo Fisher Scientific (TMO) rating was a maintained with a price target of $670.00 to $647.00. The current price Thermo Fisher Scientific (TMO) is trading at is $557.89, which is out of the analyst’s predicted range.